Advancing Personalized Medicine in Gestational Diabetes Mellitus Management Through Gut Microbiota Insights
International Journal of Molecular Sciences · 20.07.2026 · 27 (14) · 6424
DOI: 10.3390/ijms27146424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2026. Verfasst von Abdoulaye Diane und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Precision Medicine, Gastrointestinal Microbiome. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a metabolic disorder that is characterized by hyperglycemia developed or first diagnosed during pregnancy, affecting up to 15% of pregnant women worldwide. Although risk factors for GDM such as a family history of diabetes, obesity, and advanced maternal age are well recognized, the underlying pathophysiological mechanisms are complex and remain incompletely understood. Multiple studies indicate that GDM arises from a combination of peripheral insulin resistance and pancreatic β-cell dysfunction, in which insulin secretion fails to compensate for the progressive increase in insulin demand during pregnancy. In recent years, growing attention has been focused on the gut microbiota and its potential influence on the development and progression of many metabolic diseases, including GDM. Studies have shown that women diagnosed with GDM exhibited altered gut microbial composition and reduced microbial diversity, termed as “dysbiosis”, suggesting that gut microbiota dysbiosis may contribute to the pathogenesis of GDM. However, most evidence in humans is associative rather than causal, and findings vary across populations due to differences in study cohort characteristics (GDM diagnostic criteria, ethnicity, lifestyle, dietary habits, pregnancy body mass index, gestational age) and sequencing methods. Current treatment guidelines for the management of GDM are universally standardized, despite the known heterogeneity of the disease etiology. Given the inter-individual differences in gut microbial composition in women with GDM, the gut microbiota has been proposed as a promising source for rapid and specific biomarkers to enable early diagnosis, targeted prevention, and personalized management of GDM. In this narrative article, we first summarize current insights into the pathophysiological mechanisms linking gut microbiota to the development of GDM. Second, we emphasize the importance of gut microbiota analysis (or microbiomics) within multi-omics frameworks for the early detection, prevention and personalized management of GDM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- College of Health & Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
ORCID-Profile: Razik Bin Abdul Mu-U-Min
Förderung
- Qatar Biomedical Research Institute
- Hamad Bin Khalifa University
- Qatar foundation
Zitieren
APA
Diane, A., Mu-U-Min, R. B. A., & Al-Siddiqi, H. H. (2026). Advancing Personalized Medicine in Gestational Diabetes Mellitus Management Through Gut Microbiota Insights. International Journal of Molecular Sciences, 27(14), 6424. https://doi.org/10.3390/ijms27146424
Vancouver
Diane A, Mu-U-Min RBA, Al-Siddiqi HH. Advancing Personalized Medicine in Gestational Diabetes Mellitus Management Through Gut Microbiota Insights. International Journal of Molecular Sciences. 2026;27(14):6424. doi:10.3390/ijms27146424
BibTeX
@article{Diane2026,
author = {Diane, Abdoulaye and Mu-U-Min, Razik Bin Abdul and Al-Siddiqi, Heba Hussain},
title = {Advancing Personalized Medicine in Gestational Diabetes Mellitus Management Through Gut Microbiota Insights},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6424},
doi = {10.3390/ijms27146424}
}
EUVIMED